Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RXDX

Recent news which mentions RXDX

< Previous 1 2 3 Next >
Why Shares of Exscientia Jumped on Wednesday
Tickers BYM EXAI NVDA RXDX
Tags Recent Press Releases BYM SNY
From Motley Fool
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
Tickers ALPMY BLU FHLC FXH
Tags SGEN RXDX General
From Benzinga
Why Shares of Ventyx Biosciences Rose Monday
Tickers DICE LLY MRK RXDX
Tags MRK RXDX DICE
From Motley Fool
Is Merck Stock a Top Buy Right Now?
Tickers MRK RXDX
Tags Recent Press Releases Market News ^GSPC
From Motley Fool
3 Innovative Growth Stocks to Buy for Next-Gen Profits
Tickers AAPL MRK MRNA NVDA
Tags Market News MRNA NVDA
From InvestorPlace
3 Undervalued Pharma Stocks to Buy for High Total Returns
Tickers AZN MRK PFE RXDX
Tags Market News NYSE:PFE,NASDAQ:AZN,NYSE:MRK,NASDAQ:RXDX RXDX
From InvestorPlace
U.S. stocks will soon be reshuffled in the Russell reconstitution. Here’s how Goldman Sachs sees the rebalancing shaking out.
Tickers APLS CRM GOOGL META
Tags RUT WMT TMUS
From MarketWatch
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
Tickers AMGN HZNP MRK PFE
Tags RXDX General Legal
From Benzinga
FTC sues to block Amgen’s acquisition of Horizon Therapeutics
Tickers AMGN HZNP MRK PFE
Tags AMGN SGEN MRK
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Tickers AHCO ALB ALC AM
Tags Intraday Update IIPR BROS
From Benzinga
Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April
Tickers ETF MXL NET OC
Tags semiconductor OC ETF
From Benzinga
Merck’s first-quarter earnings beat estimates, even as COVID-19 treatment sales plummet
Tickers MRK RXDX SPX
Tags RXDX MRK SPX
From MarketWatch
Merck Makes a Bold Move That Could Transform Its Business
Tickers MRK RXDX
Tags Recent Press Releases Market News RXDX
From Motley Fool
3 Biotechs That Might Get Bought Out in 2023
Tickers AMLX AUPH BLU GSK
Tags MRK RXDX BLU
From Motley Fool
This Supercharged Dividend King Stock Might Soon Run Out of Steam
Tickers ABBV ABT BMY GILD
Tags Market News GILD BMY
From Motley Fool
Why Prometheus Biosciences Stock Is Skyrocketing This Week
Tickers MRK RXDX
Tags Market News Recent Press Releases RXDX
From Motley Fool
Why This Nasdaq Stock Caught Fire This Week
Tickers BLU RXDX TNYA
Tags TNYA BLU RXDX
From Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
Tickers MDGL MRK RXDX
Tags MDGL RXDX MRK
From Motley Fool
Is Merck Stock a Screaming Buy After This $11 Billion Acquisition?
Tickers ABBV JNJ MRK RXDX
Tags ABBV JNJ Recent Press Releases
From Motley Fool
Why BELLUS Health Stock Is Rocketing Higher Today
Tickers BLU GSK MRK RXDX
Tags Recent Press Releases GSK RXDX
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Tickers AQN ARCC ATER BAM
Tags LBRT NMFC CLH
From Benzinga
Expert Ratings for Prometheus Biosciences
Tickers RXDX
Tags Market News Benzinga RXDX
From Benzinga
Crude Oil Down 2%; State Street Shares Tumble After Downbeat Results
Tickers AAMC BEKE BLBX LASE
Tags News BEKE STSA
From Benzinga
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
Tickers AGEN INO MRK ROIV
Tags ROIV RXDX MRK
From Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
Tickers ALLR BIMI BLCM BNGO
Tags BIMI RXDX POAI
From Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Tickers ALLK ALLR BLBX BNGO
Tags NCMI VAPO XPEV
From Benzinga
Why Shares of Prometheus Biosciences Are Soaring Monday
Tickers MRK RXDX
Tags MRK RXDX Recent Press Releases
From Motley Fool
Gold Drops Below $2,000; Charles Schwab Earnings Top Views
Tickers AAMC AHT BLBX LASE
Tags Penny Stocks Earnings LASE
From Benzinga
Merck’s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology
Tickers ABBV BMY JNJ MRK
Tags RXDX BMY MRK
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
Tickers ADSK AES AGRO ANGO
Tags KLTR HELE Market News
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.